[Interest of systematic syphilis serology testing prior to assisted reproductive technology cycles: a retrospective study in Nantes, France].
ACTA ACUST UNITED AC 2013;
42:262-4. [PMID:
23523081 DOI:
10.1016/j.jgyn.2013.02.004]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/22/2011] [Revised: 01/29/2013] [Accepted: 02/15/2013] [Indexed: 11/23/2022]
Abstract
INTRODUCTION
Syphilis has recently re-emerged in young adults. However, serological testing of patients undergoing assisted reproductive technology (ART) cycles and/or semen cryopreservation is not mandatory in every country.
PATIENTS AND METHOD
We conducted a retrospective analysis on our local database to evaluate the prevalence of syphilis among infertile couples, and discuss the interest of systematic syphilis serology testing in these patients.
RESULTS
Between 2000 and 2010, only one patient out of 4314 was diagnosed with chronic syphilis.
CONCLUSION
This study illustrates that systematic serological screening for syphilis in couples referred for semen cryopreservation or ART only allows exceptionally rare diagnosis. The cost-effectiveness of this strategy should be reconsidered.
Collapse